Christopher Darling

Christopher Darling has a diverse work experience in various roles and industries. In 2005, they started their career as a Consultant in the Organization & Change Group at Deloitte Consulting. Christopher then joined BNP Paribas Fortis in 2007, where they held multiple roles including Head of Business Development and Associate in the Financial Institutions Group.

In 2012, Christopher briefly worked as an Associate Vice President in the Financial Institutions Group at BNP Paribas before joining Health Evolution Partners as a Summer MBA Intern in 2013.

In 2014, they became the Vice President at DQ Holdings, LLC, and also took on the role of Vice President, Head of Business Development and Operations at DermaClip US, LLC. Christopher has been instrumental in the development and promotion of the non-invasive skin closure devices offered by both companies.

Most recently, in 2021, Christopher joined DermaQuik as the Head of Business Development, where they are responsible for bringing the hospital proven technology of DermaClip to an over-the-counter skin closure device.

Christopher Darling completed a Master of Business Administration (MBA) degree in Finance, General from The Wharton School from 2012 to 2014. Prior to that, they earned a Bachelor of Arts (B.A.) degree in Economics from Boston University from 2001 to 2005.